Lincoln National Corp Shockwave Medical, Inc. Transaction History

Lincoln National Corp

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	SELL	$191.17 - $325.63 $57,733 - $98,340	-302 Reduced 21.62%	1,095 $356,000
Q4 2023 Feb 06, 2024	BUY	$160.99 - $215.69 $19,801 - $26,529	123 Added 9.65%	1,397 $266,000
Q3 2023 Nov 03, 2023	BUY	$194.33 - $283.97 $20,015 - $29,248	103 Added 8.8%	1,274 $253,000
Q2 2023 Aug 04, 2023	SELL	$223.05 - $302.68 $1,338 - $1,816	-6 Reduced 0.51%	1,171 $334,000
Q1 2023 May 01, 2023	SELL	$175.41 - $217.92 $30,345 - $37,700	-173 Reduced 12.81%	1,177 $255,000
Q4 2022 Feb 07, 2023	BUY	$204.38 - $296.82 $41,080 - $59,660	201 Added 17.49%	1,350 $277,000
Q3 2022 Nov 03, 2022	BUY	$195.21 - $310.53 $11,712 - $18,631	60 Added 5.51%	1,149 $319,000
Q2 2022 Aug 02, 2022	BUY	$115.91 - $214.48 $7,765 - $14,370	67 Added 6.56%	1,089 $208,000
Q1 2022 May 09, 2022	BUY	$127.96 - $207.36 $130,775 - $211,921	1,022 New	1,022 $211,000
Q4 2021 Jan 26, 2022	SELL	$165.13 - $241.83 $163,148 - $238,928	-988 Closed	0 $0
Q3 2021 Nov 05, 2021	BUY	$163.99 - $235.57 $162,022 - $232,743	988 New	988 $203,000

320K

1.9K

Ticker SWAV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,927,100
Description
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...

Get notified when there are updates to the investment portfolio of Lincoln National Corp, based on Form 13F filings with the SEC.

Stay updated on Lincoln National Corp with notifications on news.